Abstract:BACKGROUND:Epigenetic regulation has emerged to be the critical steps for tumorigenesis and metastasis. Multiple histone methyltransferase and demethylase have been implicated as tumor suppressors or oncogenes recently. But the key epigenomic events in cancer cell transformation still remain poorly understood.METHODS:A breast cancer transformation model was established via stably expressing three oncogenes in primary breast epithelial cells. Chromatin immunoprecipitation followed by the next-generation sequencing of histone methylations was performed to determine epigenetic events during transformation. Western blot, quantitative RT-PCR, and immunostaining were used to determine gene expression in cells and tissues.RESULTS:Histones H3K9me2 and me3, two repressive marks of transcription, decrease in in vitro breast cancer cell model and in vivo clinical tissues. A survey of enzymes related with H3K9 methylation indicated that KDM3A/JMJD1A, a demethylase for H3K9me1 and me2, gradually increases during cancer transformation and is elevated in patient tissues. KDM3A/JMJD1A deficiency impairs the growth of tumors in nude mice and transformed cell lines. Genome-wide ChIP-seq analysis reveals that the boundaries of decreased H3K9me2 large organized chromatin K9 modifications (LOCKs) are enriched with cancer-related genes, such as MYC and PAX3. Further studies show that KDM3A/JMJD1A directly binds to these oncogenes and regulates their transcription by removing H3K9me2 mark.CONCLUSIONS:Our study demonstrates reduction of histones H3K9 me2 and me3, and elevation of KDM3A/JMJD1A as important events for breast cancer, and illustrates the dynamic epigenomic mechanisms during breast cancer transformation.

Histone H3K27 Demethylases and Tumorigenesis

Roles of Histone Demethylase JMJD3 in Tumorigenesis

Histone Demethylase Lysine Demethylase 5B in Development and Cancer

The Roles of Histone Demethylase UTX and JMJD3 (KDM6B) in Cancers: Current Progress and Future Perspectives

Research Progress on Histone Demethylase JMJD3

Identification of JmjC domain-containing UTX and JMJD3 as histone H3 lysine 27 demethylases

Histone Demethylase Jumonji D3 (Jmjd3) As A Tumor Suppressor By Regulating P53 Protein Nuclear Stabilization

H3K36 trimethylation-mediated biological functions in cancer

Epigenetic roles of KDM3B and KDM3C in tumorigenesis and their therapeutic implications

Histone Methyltransferases: Novel Targets for Tumor and Developmental Defects.

JMJD3 as an epigenetic regulator in development and disease

Function of Histone Demethylasehistone Lysine-Specific Demethylase 1A in Tumor Initiation and Progression

Histone Demethylase JMJD2D: A Novel Player in Colorectal and Hepatocellular Cancers

Roles of H 3 K 27 Me 3 Demethylase JMJD 3 in Inflammation and Cancers

A histone H3 lysine 27 demethylase regulates animal posterior development

Role of Several Histone Lysine Methyltransferases in Tumor Development

JMJD1B Demethylates H4R3me2s and H3K9me2 to Facilitate Gene Expression for Development of Hematopoietic Stem and Progenitor Cells

The histone H3 Lys 27 demethylase JMJD3 regulates gene expression by impacting transcriptional elongation.

Histone Demethylase Jmjd2b Coordinates H3k4/H3k9 Methylation and Promotes Hormonally Responsive Breast Carcinogenesis

Role of the Epigenetic Modifier JMJD6 in Tumor Development and Regulation of Immune Response

Global Histone Modification Profiling Reveals the Epigenomic Dynamics During Malignant Transformation in a Four-Stage Breast Cancer Model